Citatuzumab bogatox

Citatuzumab bogatox
Monoclonal antibody
Type Fab fragment
Source Humanized (from mouse)
Target TACSTD1
Clinical data
ATC code none
Identifiers
CAS Number 945228-49-9 N
ChemSpider none
UNII 23J303Z5CA N
Chemical and physical data
Formula C3455H5371N921O1060S18
Molar mass 77.3 kg/mol
 NYesY (what is this?)  (verify)

Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]

References

  1. International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
  2. Viventia Biotech Inc.: VB6-845


This article is issued from Wikipedia - version of the 11/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.